Shenzhen Bioeasy Biotechnology Co., Ltd. (SHE:300942)
China
· Delayed Price · Currency is CNY 7.93
+0.04 (0.51%)
Apr 30, 2026, 11:54 AM CST
SHE:300942 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 3,196 | 3,812 | 3,435 | 4,686 | 6,871 | 11,569 | Upgrade
|
| Market Cap Growth | -12.58% | 10.95% | -26.69% | -31.80% | -40.61% | - | Upgrade
|
| Enterprise Value | 3,064 | 3,664 | 3,264 | 4,428 | 6,587 | 10,922 | Upgrade
|
| Last Close Price | 7.89 | 9.41 | 8.55 | 11.67 | 17.08 | 28.44 | Upgrade
|
| PE Ratio | 467.94 | 277.35 | 200.71 | - | 82.81 | 48.92 | Upgrade
|
| PS Ratio | 11.77 | 14.48 | 15.32 | 18.44 | 10.00 | 19.36 | Upgrade
|
| PB Ratio | 3.55 | 4.20 | 3.95 | 5.52 | 7.12 | 12.22 | Upgrade
|
| P/TBV Ratio | 3.73 | 4.40 | 4.14 | 5.80 | 7.45 | 12.82 | Upgrade
|
| P/FCF Ratio | - | 181.75 | - | - | - | 65.76 | Upgrade
|
| P/OCF Ratio | 57.32 | 57.00 | 100.28 | - | 45.04 | 45.29 | Upgrade
|
| EV/Sales Ratio | 11.28 | 13.92 | 14.56 | 17.43 | 9.59 | 18.28 | Upgrade
|
| EV/EBITDA Ratio | 49.29 | 65.05 | 113.76 | - | 78.20 | 42.48 | Upgrade
|
| EV/EBIT Ratio | 108.91 | 138.57 | 212.25 | - | 90.53 | 44.02 | Upgrade
|
| EV/FCF Ratio | -386.53 | 174.69 | - | - | - | 62.09 | Upgrade
|
| Debt / Equity Ratio | 0.51 | 0.49 | 0.54 | 0.43 | 0.12 | 0.04 | Upgrade
|
| Debt / EBITDA Ratio | 7.43 | 7.95 | 12.86 | - | 1.16 | 0.15 | Upgrade
|
| Debt / FCF Ratio | - | 21.34 | - | - | - | 0.23 | Upgrade
|
| Net Debt / Equity Ratio | -0.15 | -0.20 | -0.15 | -0.28 | -0.32 | -0.68 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.22 | -3.21 | -4.47 | 2.39 | -3.68 | -2.49 | Upgrade
|
| Net Debt / FCF Ratio | 17.43 | -8.61 | 0.92 | 1.42 | 12.76 | -3.64 | Upgrade
|
| Asset Turnover | 0.19 | 0.18 | 0.16 | 0.19 | 0.56 | 0.66 | Upgrade
|
| Inventory Turnover | 1.88 | 1.99 | 1.90 | 2.39 | 3.55 | 2.21 | Upgrade
|
| Quick Ratio | 6.46 | 4.63 | 4.56 | 4.98 | 2.65 | 5.02 | Upgrade
|
| Current Ratio | 7.29 | 5.09 | 4.95 | 5.39 | 3.38 | 5.73 | Upgrade
|
| Return on Equity (ROE) | 1.04% | 1.74% | 1.93% | -20.40% | 8.65% | 31.62% | Upgrade
|
| Return on Assets (ROA) | 1.20% | 1.11% | 0.68% | -5.42% | 3.74% | 17.18% | Upgrade
|
| Return on Invested Capital (ROIC) | 3.78% | 3.60% | 1.92% | -18.06% | 13.21% | 84.79% | Upgrade
|
| Return on Capital Employed (ROCE) | 2.00% | 1.90% | 1.20% | -9.40% | 6.70% | 24.90% | Upgrade
|
| Earnings Yield | 0.21% | 0.36% | 0.50% | -3.95% | 1.21% | 2.04% | Upgrade
|
| FCF Yield | -0.25% | 0.55% | -4.07% | -3.54% | -0.35% | 1.52% | Upgrade
|
| Dividend Yield | 0.23% | - | 0.20% | - | 0.12% | 0.88% | Upgrade
|
| Payout Ratio | 208.15% | 100.83% | 31.18% | - | 121.32% | 7.63% | Upgrade
|
| Buyback Yield / Dilution | -7.11% | -7.06% | -6.45% | -1.75% | -0.23% | -8.42% | Upgrade
|
| Total Shareholder Return | -6.89% | -7.06% | -6.25% | -1.75% | -0.10% | -7.54% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.